Management of multi- and extensively drug-resistant tuberculosis in Ukraine: How well are we doing?

Public Health Action

Volumn 4, Issue , 2014, Pages S67-S72

  Lytvynenko, Nataliia ^a   Cherenko, S ^a   Feschenko, Y ^a   Pogrebna, M ^a   Senko, Y ^a   Barbova, A ^a   Manzi, M ^b   Denisiuk, O ^c   Ramsay, A ^d,e   Zachariah, R ^b  

^a STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

^b Operational Centre Brussels   (Luxembourg)

^c Global AIDS Alliance   (Ukraine)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Decentralisation; MDR TB drug regimens; Operational research; SORT IT

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; QUALITY CONTROL; RETROSPECTIVE STUDY; TERTIARY CARE CENTER; TREATMENT FAILURE; TREATMENT OUTCOME; UKRAINE;

EID: 84925676835     PISSN: None     EISSN: 22208372     Source Type: Journal    
DOI: 10.5588/pha.14.0035     Document Type: Article

References (16)

1. World Health Organization. Global tuberculosis report 2013. WHO/HTM/ TB/2013.11. Geneva, Switzerland: WHO, 2013. http://apps.who.int/iris/bitst ream/10665/91355/1/9789241564656_eng.pdf. Accessed July 2014.
2. Ahuja S D, Ashkin D, Avendano M, et al. Multidrug-resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLOS MED 2012; 9: e1001300.
3. Abubakar I, Zignol M, Falzon D, et al. Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis 2013; 13: 529-539.
4. World Health Organization. Review of the National Tuberculosis Programme in Ukraine: 10-22 October 2010. Copenhagen, Denmark: WHO, 2011.
5. World Health Organization. Resolution EUR/RC61/R7. Roadmap to prevent and combat drug-resistant tuberculosis: the Consolidated Action Plan to Prevent and Combat Multidrug- and Extensively Drug-Resistant Tuberculosis in the WHO European Region, 2011-2015. Copenhagen, Denmark: WHO, 2011. http://www.euro.who.int/en/publications/abstracts/roadmap-to-preventand- combat-drug-resistant-tuberculosis Accessed July 2014.
6. Ukraine Ministry of Health. National treatment protocol No. 1091. Kiev, Ukraine Ministry of Health, 2012.
7. Ukraine Ministry of Health. National tuberculosis management guidelines. Kiev, Ukraine Ministry of Health, 2012.
8. World Health Organization. Global laboratory initiative: SRL network. Geneva, Switwerland: WHO, 2014. http://www.stoptb.org/wg/gli/srln.asp Accessed July 2014.
9. von Elm E, Altman D G, Egger M, Pocock S J, Gotzsche P C, Vandenbroucke J P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-1457.
10. Edginton M, Enarson D, Zachariah R, et al. Why ethics is indispensable for good quality operational research. Public Health Action 2012; 2: 21-22.
11. Jakubowiak W M, Bogorodskaya E M, Borisov S E, Danilova I D, Kourbatova E V. Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions. Int J Tuberc Lung Dis 2007; 11: 46-53.
12. Jakubowiak W M, Bogorodskaya E M, Borisov S E, Danilova I D, Lomakina O B, Kourbatova E V. Impact of socio-psychological factors on treatment adherence of TB patients in Russia. Tuberculosis (Edinb) 2008; 88: 495-502.
13. Post F A, Grint D, Werlinrud A M, et al. Multidrug-resistant tuberculosis in HIV positive patients in Eastern Europe. J Infect 2014; 68: 259-263.
14. Brust J C, Shah N S, Scott M, et al. Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care. Int J Tuberc Lung Dis 2012; 16: 998-1004.
15. Isaakidis P, Varghese B, Mansoor H, et al. Adverse events among HIV/ MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India. PLOS ONE 2012; 7: e40781.
16. Van Deun A, Maug A K, Salim M A, et al. Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2010; 182: 684-692.